We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




How Foods Fight Cancer

By Biotechdaily staff writers
Posted on 25 Jul 2005
"Compounds like sulforaphane in broccoli and resveratrol in wine have been shown to prevent cancer. More...
They do that by signaling our bodies to ramp up the production of proteins capable of preventing damage to our DNA. We now have a good idea how that signal works,” said Dr. Andrew Mesecar, associate professor of pharmaceutical biotechnology at the University of Illinois at Chicago (UIC) College of Pharmacy (USA), following a recent study.

Two major proteins, Keap1 and Nrf2, are involved in prompting the fight against cancer when disease-preventing foods are ingested, according to the UIC researchers. Keap1, the sensor protein, detects the presence of dietary substances such as sulforaphane when they bind with its cysteine residues, one of the amino acids that make up proteins. Keap1 attaches to Nrf2, the messenger that activates the genes for the protective proteins, avoiding DNA damage.

"Earlier studies in mice suggested that natural cancer-preventing compounds worked by severing the tie between Keap1 and Nrf2, freeing Nrf2 to take action,” Dr. Mesecar remarked. "But the signaling doesn't happen this way in humans.”

The researchers discovered that in humans the connection between the two proteins is not disrupted. What is significant, the investigators reported, is the alteration of cysteines in Keap1. They discovered that one specific cysteine was among the most likely to be modified in the interaction with cancer-preventing compounds.

This finding corresponded with results from other researchers. As a result, the scientists are proposing that the alteration of only this one amino acid in Keap1 is the critical step that triggers increases of the messenger Nrf2, and as a result, increased production of the protective proteins.

Keap1 is a potential new target for drugs to combat many different types of cancer, according to Dr. Mesecar. "One way of preventing cancer may be to eat certain foods rich in cancer-preventing compounds. An alternative is identifying how these compounds work and replicating their modes of action with drugs,” noted Dr. Mesecar.

The study was published in the June 12, 2005, online edition of the Proceedings of the [U.S.] National Academy of Sciences.




Related Links:
University of Illinois at Chicago

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Automatic CLIA Analyzer
Shine i6000
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Longitudinal Heart Stress Assessment Improves Prediction of Cardiovascular Outcomes

Accurately predicting cardiovascular disease (CVD) risk in older adults is challenging when assessments rely on single, point-in-time biomarker measurements. Dynamic indicators that reflect evolving cardiac... Read more

Molecular Diagnostics

view channel
Image: Patient-collected swabs showed nearly twice the rate of high-risk HPV positivity reported in a recent large cervical cancer screening study in Washington (Image Credit: Adobe Stock)

Self-Collected HPV Testing Reaches Patients Missed by Routine Screening

Timely cervical cancer screening prevents progression from persistent high‑risk human papillomavirus (HPV) infection, yet many adults marginalized from care do not complete routine exams.... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.